Summary. The facilitative effects of certain progestational steroids on ovulation were investigated by using 25-day-old female rats which had been treated on Day 22 with a non-ovulatory dose of PMSG (12 i.u.). Ovulation was caused by treatment with pregnenolone or progesterone on the morning of Day 24. The dose of pregnenolone required was higher than that of progesterone. Progesterone had this effect throughout the morning of Day 24, while prenenolone was only effective between 07.00 and 10.00 hours on Day 24. The two metabolites of progesterone in the hypothalamus and uterus, 5\g=a\-dihydroprogesterone and 3\ g=a\ \ x =r eq-\ hydroxy-5\m=infty\-pregnan-20-one, were also tested for their ability to cause ovulation. Although 5\g=a\-dihydroprogesteronepossessed this ability, a dose three to four times that of progesterone was required to produce a comparable effect. Doses of up to 1 \m=.\5 mg 3\g=a\-hydroxy-5\g=a\-pregnan-20-one were without effect. Neither 17\g=a\-hydroxypregnenolone nor 17\g=a\-hydroxyprogesterone had any effect in influencing ovulation.
INTRODUCTION
The ability of progesterone to influence ovulation in rats is well recognized although the mechanisms involved are not well understood (Zarrow & Hurlbut, 1967;  Caligaris, Astrada & Taleisnik, 1968; Zarrow & Gallo, 1969; Arimura & Schally, 1970) . McCormack & Meyer (1962) showed that progesterone on Day 24 increased the incidence of ovulation in rats when they had been given a single dose of 15 i.u. PMSG on Day 22. In rats of the same age treated with 3 i.u. PMSG, Ying & Meyer (1969a) demonstrated that progesterone will advance ovulation by 24 hr when given at 10.00 hours on Day 23 but will postpone ovulation by 24 or 48 hr when given on Day 22. It has been shown by many workers that phénobarbital (PB) and other neuropharmacological agents will block ovulation when given before the critical period on the day of pro-oestrus in adults or PMSG-primed immature rats (Everett & Sawyer, 1950; Strauss & Meyer, 1962; Zarrow & Brown-Grant, 1964) . This block of ovulation could be prevented if progesterone was given before the PB treatment. In 22-day-old rats treated with 3 i.u. PMSG, Ying & Meyer (1969c) blocked ovulation by injection of PB on Day 24. An injection of progesterone did restore ovulation, but injection of pregnenolone acetate in doses up to 4 mg did not restore ovulation in these rats. Meyer, Karavolas, Klausing & Norgard (1971) reported that rats treated with PB and primed with PMSG showed a decrease in plasma progesterone levels and an increase in the levels of pregnenolone, suggesting that PB inhibits the conversion of pregnenolone to progesterone. These findings were sup¬ ported and extended by the work of Karavolas, Gupta & Meyer (1972 (Karavolas et al., 1972) .
Gupta , in their work on the ovaries of PMSG-treated immature rats, proposed that the intermediate compound in the conversion of pregnenolone to progesterone in the rat ovary is pregn-5-ene-3,20-dione, thereby suggesting that the first enzyme to act on pregnenolone is 3/?-hydroxysteroid dehydrogenase and is followed by the action of 4""5 isomerase as has been shown with other steroidogenic tissues and species (Cheatum & Warren, 1960; Ewald, Werbin & Chaikoff, 1964; Cheatum, Douville & Warren, 1967) . Furthermore, they suggested that the activity of 3/?-hydroxysteroid dehydro¬ genase is affected by treatment with PB as they recovered lower amounts of 14C associated with pregn-5-ene-3,20-dione in the PB-treated groups. If this interference by PB with the conversion of pregnenolone to progesterone and its subsequent metabolites affects the optimal steroidal environment essential for the regulation of ovulation, then it should be possible to demonstrate the ability of pregnenolone to facilitate ovulation in a test system where PB is not present. Such a test system is provided by the 22-day-old rats treated with 12 i.u. PMSG where the incidence of spontaneous ovulation is low (Ying & Meyer, 1969b; Ying, 1969) . McCormack & Meyer (1964) showed that a small dose of progesterone in these animals would cause ovulation in 100% of the animals.
In these animals, pregnenolone administration should, by virtue of its con¬ version into progesterone, induce ovulation. Karavolas & Herf (1971) and Cheng & Karavolas (1973) conducted studies on the uptake and metabolism of labelled progesterone in the medial basal hypothalamus of rats in pro-oestrus. They reported that progesterone was converted into two metabolites, 5a-dihydroprogesterone (5a-pregnan-3,20-dione) and 3a-hydroxy-5a-pregnan-20-one. Interestingly, the same two steroids had been reported by Armstrong & King (1971) and Wiest (1963) 
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The steroids (1-5 mg in corn oil) were injected subcutaneously. Table 3 shows Table 4 . Effect of 17a-hydroxypregnenolone, 17a-hydroxy-progesterone, 5a-dihydroprogesterone and 3a-hydroxy-5a-pregnan-20-one in facilitating ovulation on Day 24 in rats treated with 12 i.u. the results when two groups of rats were injected with progesterone on Day 23. The rate of ovulation decreased to 20% when progesterone was given at 18.00 hours on Day 23 and the facilitative effect of progesterone was absent or there was an inhibitory effect when the steroid was injected at 14.00 hours.
The potentiating action of 17a-hydroxypregnenolone and 17a-hydroxyprogesterone was tested and the results are shown in Table 4 . Neither steroid appeared to have any facilitative effect. Injections of 1-5 and 2-0 mg 5 -dihydroprogesterone caused ovulation in all the treated animals (Table 4) , but 3a-hydroxy-5a-pregnan-20-one did not have any effect. The steroid, pregn-5-ene-3,20-dione, was found to have a strong facilitative action (Table 5) . A comparison with the effects of equal doses of progesterone shows that the action of pregn-5-ene-3,20-dione was equal to that of progesterone in doses of 0-25 mg or higher. In lower doses, progesterone appeared to have a slightly greater effect than pregn-5-ene-3,20-dione, but the difference was not statistically significant ( 2 = 1-72, P>0-1).
DISCUSSION
The mechanism(s) by which PB and other neuropharmacological agents inhibit ovulation in PMSG-primed immature rats has been postulated by Ying & Meyer (1969c) to be due probably to their interference with the metabolism and/or synthesis of steroids essential for the neural regulation of ovulation or an alteration of thresholds of excitability in the hypothalamus which controls the release of the gonadotrophin necessary for ovulation.
Animals treated with PB show reduced amounts of progesterone and higher amounts of pregnenolone in the blood (Meyer et al., 1971 pregn-5-ene-3,20-dione ovulated. It may be that pregn-5-ene-3,20-dione need not be converted into progesterone for its facilitatory activity, since its effect is equal to that of progesterone. On the other hand, in the light of the high turnover numbers associated with the 4-5 isomerase, it is possible that pregn-5-ene-3,20-dione is rapidly converted to progesterone. Additionally, if an increase in the activity of 4-5 isomerase in PB-treated animals is postulated, then an accelerated conversion of pregn-5-ene-3,20-dione into progesterone would result and ovulation would be potentiated.
In the animals treated with PB, increased pregnenolone and decreased progesterone were found (Meyer et al., 1971; Norman & Greenwald, 1971; Karavolas et al., 1972) . In animals treated with PB, the conversion of pregnen¬ olone to progesterone is inhibited and the optimal ratio of oestrogen : pro¬ gesterone for ovulation is not attained. Inhibitors of enzymes that catalyse reactions during steroidogenesis in the ovary have been investigated recently and found to have an inhibitory effect on ovulation (Lipner & Greep, 1971; Lipner & Wendelken, 1971 ). On the basis of the present experiments, it is suggested that the ovulation which occurs 24 hr after the PB-induced block, is due to the conversion of accumulated pregnenolone to progesterone as the effect of the drug is attenuated.
